Anthropic has launched Claude Science, a new flagship product designed to support scientific research, marking a significant expansion of generative AI into critical sectors like pharmaceuticals and biotechnology.
What happened
Anthropic, a leading AI company, unveiled Claude Science at an event for pharmaceutical executives, biotech founders, and researchers MIT Technology Review AI - The Download: Anthropic launches Claude Science. This new tool is specifically optimized to address the challenges of scientific research, promising to accelerate discovery and complex data analysis. The goal is to provide advanced support for understanding scientific texts, generating hypotheses, and processing experiments, pushing the boundaries of innovation in knowledge-intensive fields.
Concurrently, AI's application is extending far beyond chatbots and image generators, becoming a core operating layer in industries with complex physical infrastructure, where operational continuity and safety are paramount. Examples include optimizing wind turbines and managing large-scale industrial systems MIT Technology Review AI - Teaching AI to run with the turbines. AI is being used to improve operational efficiency, predict failures, and optimize processes, as demonstrated by the adoption of frameworks like Lean Six Sigma and Business Process Management (BPM) enhanced by AI to achieve operational excellence MIT Technology Review AI - Achieving operational excellence with AI.
Why it matters
The introduction of tools like Claude Science has the potential to revolutionize the scientific research lifecycle. By reducing analysis times and facilitating the synthesis of vast amounts of literature, AI can accelerate the development of new drugs, materials, and therapies. This not only leads to faster progress but can also make research more accessible, democratizing access to advanced analytical tools. However, it also raises questions about the validation of AI-generated results and the need to maintain rigorous human oversight.
In the industrial context, integrating AI into critical systems means greater efficiency, reduced operational costs, and improved safety. AI can constantly monitor complex parameters, identify anomalies before they become problems, and optimize performance in real-time. This directly impacts labor productivity, requiring new skills for managing and supervising autonomous systems, and shifting human focus towards higher-value, strategic roles.
The HDAI perspective
The expansion of AI into such sensitive sectors as scientific research and critical industrial operations underscores the urgency of an ethical and responsible approach. The philosophy of Human Driven AI is more relevant than ever: it's not just about maximizing efficiency or speed of discovery, but about ensuring these advancements align with human values, safety, and transparency. It is crucial that generative AI tools like Claude Science are developed with integrated audit mechanisms and that researchers and industrial operators are adequately trained to understand the limitations and potential biases of these systems.
AI governance in these areas is not an option, but a necessity to protect scientific integrity and operational safety. We must ensure that AI is an empowering co-pilot, not an uncritical replacement for human judgment, especially when decisions have direct implications for health, safety, and the environment. Topics such as model robustness, explainability of decisions, and the prevention of systemic errors will be central to discussions at the upcoming HDAI Summit 2026 in Pompeii, where global experts will debate how to balance innovation and responsibility.
What to watch
It will be crucial to observe how regulations, particularly the EU AI Act, adapt to these new AI applications in high-risk sectors. Collaboration among AI developers, scientists, engineers, and regulators will be fundamental to defining standards that promote responsible innovation and ensure public trust in the use of artificial intelligence for the common good.